Can anyone enlighten me on the process and time frame of this reverse merger?
Many thanks in advance for your response.
they definitely not getting my approval for the merger unless they remove these parachutes. If I crash, you crash. play it fair incompetent management.
SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M /Undiscovered Stock/ Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..Please do your own dd and realize the Monster Potential here .Thank me later
Sonoma Pharma (Nasdaq: SNOA)
Market Cap: 22.1 Million Cash: $12.6 Million Price: $5.15
Driving to commercial EBITDAS breakeven, without dilution
Grow current product portfolio with all sales people
•Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment •Mondoxyne for severe acne –launched late 2015 •Ceramax for skin repair in atopic dermatitis–launched in April 2016 •SebuDerm for seborrhea dermatitis –launched in November 2016
Launch 3 New Products –our product pipeline –one every other quarter
•Launching Loyon–Fall 2017 •Ceramax in foam and gel forms –Q4 2017 & Q1 2018
Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.
We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.
Hard to believe how any of you longs can be surprised by the scoundrels running this dead company starting with "The Little Ape In Flats" and now incompetent Zaccardelli, his incompetent management and BOD.
This company has engaged in lies, fraud, and corruption from its inception. When the Soli P3 trial failed, what did management do? They gave themselves promotions and salary increases. By December of this year, they will have gone thru $80M with nothing to show for it except looking out for themselves.
Now they have given themselves golden parachutes and should all go to jail and you are surprised.
When a company tells you who they are, believe them. They made themselves very clear. They told you they were con men, and you still brought into their BS. You have nobody to blame but yourselves. This was a scam from day 1.
CEMP may be a compelling opportunity. google awesom*sto-cks - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
What does this company have other than cash? That will vanish after the "Golden Parachutes". I am surprised the founder of this company has not been sued by shareholders for withholding the liver enzyme debacle of the Antibiotic that was turned down by the FDA..
seriously? where is this incompetent management drove this company to? the sewers?
wonder what bacterial disease solithromycin and baxdela combo can cure
I bet that a lot of lawsuits will be forthcoming, it's the old raiding of the coffers!!!
Im actually beginning to think the market for ABSSSI /MRSA may be twice as large as for CABP. 119,000 deaths for MRSA 59,000 for CABP. If Baxdella has twice the sales potential as Soli and we own half,then share price should be worth above $25 today.
Woohoo! Trading halted. Still have some calls in CEMP. Will I be retiring early? LOL
Where's the bottom on this. Seems to me Melinta is getting a pretty good deal here. I think the real value in this merger is about 90% Melinta. Not sure why they didn't just go IPO on their own though. Market Cap now $152M. Seems too low to me.
Does anyone here who is smarter than me have any idea what longs should do here? What would be a good move for people holding calls? The markets reaction to the news today is hard to translate.
Way oversold. We are going to go back up over next few weeks.
CEMP is public company, why wouldn't CEMP buy Melinta and just stay CEMP? Must be a lot of rocket surgeons and brains scientists who thought this deal up, or just plain cash raiders....
Market reaction is crazy IMO.The combined value is worth more than the entities. The value of Melinta is substantial. Overhead will be halved for each company.One board ,one marketing staff.Multiple products .One ready to stream income.
will this turd ever go go back up?
WTH ??? hopefully a good buy opportunity.
Interesting read in edited transcript...
Merger with Melinta...looking for a new ceo...Charles, are you available?